JGV logo Journal of General Virology

First posted online 16 January 2001 ARTICLE ABSTRACT
Rec 12 October 2000; Acc 22 December 2000 DOI: 10.1099/vir.0.17472-0

Human telomerase reverse transcriptase-immortalized MRC-5 and HCA2 human fibroblasts are fully permissive for human cytomegalovirus

B. P. McSharry,1 C. J. Jones,2 J. W. Skinner,2 D. Kipling2 and G. W. G. Wilkinson1

Department of Medicine, Tenovus Building1 and Department of Pathology2, University of Wales College of Medicine, Heath Park, Cardiff CF14 4XX, UK


MRC-5 cells are a well-characterized human diploid fibroblast cell line approved for vaccine production and favoured for the routine propagation of human cytomegalovirus (HCMV). Ectopic expression of telomerase in fibroblasts is capable of overcoming replicative senescence induced by telomere shortening. Following delivery of the hTERT gene to MRC-5 cells using a retrovirus vector three clones were generated that (i) expressed functional telomerase activity, (ii) exhibited telomere extension and (iii) were sustained for >100 population doublings. Immortalized MRC-5-hTERT and also HCA2-hTERT human fibroblasts were both fully permissive for HCMV as determined by plaque assay, studies of virus growth kinetics and measurement of virus yields. Furthermore, telomerase-immortalized HCA2 cells proved capable of supporting the stable maintenance of an EBV-based episomal vector with efficient transgene expression when driven by the HCMV immediate early promoter. An indicator cell line suitable for the efficient detection of HCMV infection was also generated using an episome containing a reporter gene (lacZ) under the control of the HCMV beta-2.7 early promoter. Telomerase immortalization of human fibroblasts will thus facilitate the growth and detection of HCMV and also the generation of helper cell lines for the propagation of HCMV deletion mutants. Immortalization of fibroblasts by telomerase does not affect cell morphology or growth characteristics. The MRC-5-hTERT clones may therefore be suitable for additional applications in virology, cell biology, vaccine production and biotechnology.

Get textClick here for full text HTML

UpJGV Direct table of contents

© 2001 SGM

This article is now available in the April 2001 print issue of JGV (vol. 82, 855–863). The complete issue of the journal may be seen in electronic form on JGV Online.